{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-043322","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2024-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.977987+00:00","generated_at":"2026-05-30T06:56:41.954066+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BriaPro sub of BriaCell reports $420K net loss, going concern uncertainty","bullets":["BriaPro incurred net loss of $420,287 for year ended July 31, 2024; accumulated deficit $440,209 since incorporation in May 2023.","Total assets $199,797; current liabilities $455,650; shareholders' deficit $405,694; cash balance $1.","Auditor's report includes material uncertainty paragraph about going concern; company is pre-clinical with no commercial operations.","Intangible assets (patents) of $199,796 acquired from BriaCell via spinout arrangement on August 31, 2023.","BriaCell beneficially owns 2/3 of BriaPro's outstanding common shares (31,963,452 of 47,945,178 shares)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-043322","json":"https://secwatch.observer/filing/0001493152-24-043322.json","markdown":"https://secwatch.observer/filing/0001493152-24-043322.md","text":"https://secwatch.observer/filing/0001493152-24-043322.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000149315224043322/0001493152-24-043322-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000149315224043322/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T06:56:41.954066+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}